Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc.

World Rank (Jan-05-2024)
17,561
Market Cap (Jan-05-2024)
0.213 Billion USD
World Rank (Jul-30-2023)
17,950
Market Cap (Jul-30-2023)
0.204 Billion USD
World Rank (Jan-07-2022)
16,648
Market Cap (Jan-07-2022)
0.295 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
LCTX
Market Cap (Mar-08-2026)
0.43
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
LINEAGE CELL THERAPEUTICS, INC.
Company Profile
Lineage Cell Therapeutics is a Clinical Stage Biotechnology company developing novel cellular therapies to treat unmet medical needs. The company total assets are 107.9 million USD as on 2020. The headquarters is in USA.
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share